Skip to content

Free cash flow at other companies

Biogen logo
BiogenBIIB
$594.3M+167%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$59.56M-0.8%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$60.24M-107%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
BridgeBio Pharma logo
BridgeBio PharmaBBIO
TG Therapeutics logo
TG TherapeuticsTGTX

Other financials

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M

Valuation

See full
Market cap$3.7B+37.0%
Enterprise value$3.47B+36.6%
P/E9.9×-2.0×
P/S3.4×+0.7×

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
Net margin34.3%+11.3pp
FCF margin18.9%

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0.0×
Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Pharmaceuticals's free cash flow?
Acadia Pharmaceuticals (ACAD) reported free cash flow of $28.77M in Q1 2026.
How has Acadia Pharmaceuticals's free cash flow changed year-over-year?
Acadia Pharmaceuticals's free cash flow increased by 41.6% year-over-year, from $20.32M to $28.77M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.